Mirtazapine Tablet
Product Images NDC 42291-494

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 42291-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (Mirt)

Mirtazapine Tablets USP 7.5 mg oral tablets by AvKARE. The label indicates a package containing 30 tablets with directions for the pharmacist to dispense with a medication guide. The label includes dosage strength, NDC 42291-494-30, and storage instructions to protect from heat and store at controlled room temperature.*

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular framework with nitrogen-containing rings and a methyl group attached to a nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.